Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
Diabetes|November 4, 2018
Senescent T Cells Predict the Development of Hyperglycemia in HumansYong-Ho Lee, So Ra Kim, Dai Hoon Han, et al.
Diabetes, Obesity & Metabolism|December 24, 2022
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trialYong-Ho Lee, Doo-Man Kim, Jae Myung Yu, et al.
Frontiers in Immunology|May 16, 2022
Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21Eun Ran Kim, So Ra Kim, Wonhee Cho, et al.
The Clinical Journal of Pain|February 27, 2022
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 TrialKyung Ah Han, Yong-Ho Lee, Hyun-Shik Son, et al.
BMC Medicine|September 6, 2022
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signalingSeul-Gee Lee, Darae Kim, Jung-Jae Lee, et al.
Nature Communications|February 5, 2025
Regulation of senescence-associated secretory phenotypes in osteoarthritis by cytosolic UDP-GlcNAc retention and O-GlcNAcylationDonghyun Kang, Jeeyeon Lee, Geunho Yook, et al.
Clinical Hypertension|November 1, 2021
Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)Il Suk Sohn, Sang-Hyun Ihm, Gee Hee Kim, et al.
Korean Circulation Journal|March 11, 2020
Anti-Inflammatory Effect for Atherosclerosis Progression by Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic Rabbit ModelSeul Gee Lee, Seung Jun Lee, Jung Jae Lee, et al.
Advances in Therapy|June 16, 2024
Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational StudyHae Jin Kim, Kyu Yeon Hur, Yong-Ho Lee, et al.
Hepatology (Baltimore, Md.)|November 13, 2021
A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeEun Ran Kim, Jeong Su Park, Jin Hee Kim, et al.
Pageof 36